Back to ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

ABUSABUS
6 quarters

Position history for ARROWSTREET CAPITAL, LIMITED PARTNERSHIPARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in ARBUTUS BIOPHARMA CORP

Yes. Arrowstreet Capital holds 650,700 shares of ABUS (Arbutus Biopharma), worth $3.1M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$3.1M

Current Shares

650,700

Total Value Change

+$3M

Total Shares Change

+588,379

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
650,700
-
$3.1M0.0%$4.80
37
2026-Q1
Exited
0
-100.0%
$00.0%$4.50
0
2025-Q4
Decreased
35,116
-77.9%
$168,9080.0%$4.81
0
2025-Q3
New
159,118
-
$722,3960.0%$4.54
34
2020-Q3
Exited
0
-100.0%
$00.0%$3.13
0
2020-Q2
New
62,321
-
$113,0000.0%$1.82
30

Other major holders of ABUS: MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used